Resmed Cdi news

RMD · ASX · AUD

$31.78−0.69%−$0.22

Close · October 7, 2026

Latest news

ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings? (opens in a new tab)
StockStory · Oct 5, 2026
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026 (opens in a new tab)
GlobeNewswire · Oct 1, 2026
This Stock Could Be the Big Winner Out of Oura’s IPO (opens in a new tab)
Barrons.com · Sep 28, 2026
Is ResMed A Better Way Than Stryker To Own Medical Device Growth? (opens in a new tab)
Trefis · Sep 28, 2026
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand (opens in a new tab)
MarketBeat · Sep 21, 2026
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures (opens in a new tab)
Insider Monkey · Sep 19, 2026
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like. (opens in a new tab)
Barrons.com · Sep 15, 2026
This Analyst Just Upgraded ResMed Stock. Here's Why. (opens in a new tab)
Barchart · Sep 15, 2026
Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)? (opens in a new tab)
Simply Wall St. · Sep 15, 2026
ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says (opens in a new tab)
MT Newswires · Sep 15, 2026
Is This the Right Time to Retain Resmed Stock in Your Portfolio? (opens in a new tab)
Sep 15, 2026
Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls (opens in a new tab)
Sep 15, 2026
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More (opens in a new tab)
Sep 15, 2026
Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest (opens in a new tab)
Sep 14, 2026
ResMed Stock: Is RMD Underperforming the Healthcare Sector? (opens in a new tab)
Sep 14, 2026
Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer (opens in a new tab)
Sep 1, 2026
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference (opens in a new tab)
Aug 27, 2026
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference (opens in a new tab)
GlobeNewswire · May 19, 2026
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off (opens in a new tab)
StockStory · Oct 2, 2026
2 Profitable Stocks Worth Investigating and 1 We Turn Down (opens in a new tab)
Sep 1, 2026
2 S&P 500 Stocks with Promising Prospects and 1 We Ignore (opens in a new tab)
Aug 27, 2026